These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27287780)

  • 1. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
    Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
    Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer.
    Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
    J Clin Oncol; 2016 Feb; 34(4):321-8. PubMed ID: 26628465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.
    Keymeulen KBIM; Geurts SME; Kooreman LFS; Duijm LEM; Engelen S; Vanwetswinkel S; Luiten E; Siesling S; Voogd AC; Tjan-Heijnen VCG
    Eur Radiol; 2023 Mar; 33(3):2209-2217. PubMed ID: 36180645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
    Susnik B; Schneider L; Swenson KK; Krueger J; Braatz C; Lillemoe T; Tsai M; DeFor TE; Knaack M; Rueth N
    J Surg Oncol; 2018 Jul; 118(1):221-227. PubMed ID: 30196538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
    Gao X; Fisher SG; Emami B
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease?
    Lamb LR; Oseni TO; Lehman CD; Bahl M
    Eur J Radiol; 2020 Aug; 129():109130. PubMed ID: 32634736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
    Tendulkar RD; Chellman-Jeffers M; Rybicki LA; Rim A; Kotwal A; Macklis R; Obi BB
    Cancer; 2009 Apr; 115(8):1621-30. PubMed ID: 19224552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?
    Hajaj M; Karim A; Pascaline S; Noor L; Patel S; Dakka M
    Eur J Radiol; 2017 Oct; 95():271-277. PubMed ID: 28987679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.
    Henderson LM; Weiss J; Hubbard RA; O'Donoghue C; DeMartini WB; Buist DS; Kerlikowske K; Goodrich M; Virnig B; Tosteson AN; Lehman CD; Onega T
    Breast J; 2016; 22(1):24-34. PubMed ID: 26511204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National trends of synchronous bilateral breast cancer incidence in the United States.
    Sakai T; Ozkurt E; DeSantis S; Wong SM; Rosenbaum L; Zheng H; Golshan M
    Breast Cancer Res Treat; 2019 Nov; 178(1):161-167. PubMed ID: 31325072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
    Wu WP; Chen CY; Lee CW; Wu HK; Chen ST; Wu YT; Lin YJ; Chen DR; Kuo SJ; Lai HW
    PLoS One; 2021; 16(11):e0260093. PubMed ID: 34793522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.
    Kim JY; Cho N; Koo HR; Yi A; Kim WH; Lee SH; Chang JM; Han W; Moon HG; Im SA; Noh DY; Moon WK
    Radiology; 2013 Apr; 267(1):57-66. PubMed ID: 23329656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.
    Nori J; Meattini I; Giannotti E; Abdulcadir D; Mariscotti G; Calabrese M; Angelino F; Chiesa F; Saieva C; Vanzi E; Boeri C; Bianchi S; Sanchez L; Orzalesi L; Casella D; Susini T; Livi L
    Breast J; 2014; 20(3):243-8. PubMed ID: 24750509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.
    Brennan ME; Houssami N; Lord S; Macaskill P; Irwig L; Dixon JM; Warren RM; Ciatto S
    J Clin Oncol; 2009 Nov; 27(33):5640-9. PubMed ID: 19805685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.
    Ozanne EM; Weiss JE; Onega T; DeMartini W; Kerlikowske K; Buist DS; Henderson L; Hubbard RA; Goodrich M; Tosteson AN; Virnig BA; O'Donoghue C
    Am J Surg; 2017 Jan; 213(1):132-139.e2. PubMed ID: 27421187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.